827 related articles for article (PubMed ID: 18694635)
1. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
5. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.
Kieser M; Szegedi A
Pharmacopsychiatry; 2005 Sep; 38(5):194-200. PubMed ID: 16189745
[TBL] [Abstract][Full Text] [Related]
6. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design.
Kasper S; Dienel A; Kieser M
Int J Methods Psychiatr Res; 2004; 13(3):176-83. PubMed ID: 15297901
[TBL] [Abstract][Full Text] [Related]
7. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
Kasper S; Dienel A
Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
[TBL] [Abstract][Full Text] [Related]
10. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
Amsterdam JD; Bodkin JA
J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
[TBL] [Abstract][Full Text] [Related]
11. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
12. Suicidal thinking and behavior during treatment with sertraline in late-life depression.
Nelson JC; Delucchi K; Schneider L
Am J Geriatr Psychiatry; 2007 Jul; 15(7):573-80. PubMed ID: 17586782
[TBL] [Abstract][Full Text] [Related]
13. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
Munizza C; Olivieri L; Di Loreto G; Dionisio P
Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
[TBL] [Abstract][Full Text] [Related]
14. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
Brenner R; Azbel V; Madhusoodanan S; Pawlowska M
Clin Ther; 2000 Apr; 22(4):411-9. PubMed ID: 10823363
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and acceptability of tianeptine and sertraline in the acute treatment phase of depression].
Szádóczky E; Füredi J
Encephale; 2002; 28(4):343-9. PubMed ID: 12232543
[TBL] [Abstract][Full Text] [Related]
17. Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trial.
Rickels K; Montgomery SA; Tourian KA; Guelfi JD; Pitrosky B; Padmanabhan SK; Germain JM; Leurent C; Brisard C
J Clin Psychopharmacol; 2010 Feb; 30(1):18-24. PubMed ID: 20075643
[TBL] [Abstract][Full Text] [Related]
18. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
Mannel M; Kuhn U; Schmidt U; Ploch M; Murck H
J Psychiatr Res; 2010 Sep; 44(12):760-7. PubMed ID: 20181361
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
20. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
